New therapeutic agents for acromegaly
New therapeutic agents for acromegaly
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Available medical therapies for acromegaly are limited by moderate and variable efficacy, the need for life-long monthly intramuscular and/or deep subcutaneous depot, or thrice-daily subcutaneous injections, as well as adverse effects
DG3173, an injectable somatostatin receptor ligand (SRL) in development, selectively suppresses se...
Alternative Titles
Full title
New therapeutic agents for acromegaly
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1760894699
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1760894699
Other Identifiers
ISSN
1759-5029
E-ISSN
1759-5037
DOI
10.1038/nrendo.2015.196
